tetano
Editor, Senior Moderator
Open Access Emerg Med
. 2025 Jan 22:17:15-30.
doi: 10.2147/OAEM.S470523. eCollection 2025. Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series
Lyudmila Pivina[SUP] 1 [/SUP], Gulnara Batenova[SUP] 1 [/SUP], Nazarbek Omarov[SUP] 1 [/SUP], Diana Ygiyeva[SUP] 1 [/SUP], Assylzhan Messova[SUP] 1 [/SUP], Galiya Alibayeva[SUP] 2 [/SUP], Ulzhan Jamedinova[SUP] 1 [/SUP], Ruslan Kurumbayev[SUP] 1 [/SUP], Maksim Pivin[SUP] 3 [/SUP]
Affiliations
Background: One of the most serious complications of coronary artery stenting is restenosis and in-stent thrombosis; their prevalence can reach 20-25%. Stent thrombosis can be acute (up to 24 hours), subacute (24 hours to 30 days), late (30 days to 1 year), and very late (> 1 year after previous stenting). In the patients with COVID-19 in intensive care units, the proportion of those with elevated troponin levels reached 25%.
Objective: Evaluation of the association between COVID-19 and the development of in-stent thrombosis and restenosis of the coronary arteries based on the analysis of clinical cases and case series.
Materials and methods: We searched the PubMed and Scopus databases for relevant case reports and case series of stent restenosis and in-stent thrombosis associated with coronavirus infection (CVI) published between 2020 and the present. Thirty-eight full-text publications were screened and manually checked for analysis. We found 10 publications describing cases of thrombosis and restenosis of stents associated with coronavirus infection, of which only 2 were case series. In total, we analyzed 22 cases.
Results: In the structure of in-stent restenosis and thrombosis, 59.1% were very late, 9.1% were late; 18.2% were considered subacute events, and 13.6% were acute events. All cases were angiographically confirmed. The main location of restenosis or thrombosis was the left coronary artery (LAD) (51.1%), thrombosis of the right coronary artery (RCA) occurred in 27.3%, and location in circumflex artery was in 22.7%. All patients had COVID-19 confirmed by a PCR test or the presence of immunoglobulins G and M. In fourteen patients (54.5%), an X-ray examination showed the presence of bilateral polysegmental infiltration.
Conclusion: Analysis of publications demonstrates the association between restenosis and in-stent thrombosis in patients with coronary arteries disease (CAD) and coronavirus infection.
Keywords: COVID-19; case report; case series; coronary artery disease; in-stent thrombosis; restenosis; stenting.
. 2025 Jan 22:17:15-30.
doi: 10.2147/OAEM.S470523. eCollection 2025. Peculiarities of in-Stent Thrombosis and Restenosis in Coronary Arteries Post-COVID-19: A Systematic Review of Clinical Cases and Case Series
Lyudmila Pivina[SUP] 1 [/SUP], Gulnara Batenova[SUP] 1 [/SUP], Nazarbek Omarov[SUP] 1 [/SUP], Diana Ygiyeva[SUP] 1 [/SUP], Assylzhan Messova[SUP] 1 [/SUP], Galiya Alibayeva[SUP] 2 [/SUP], Ulzhan Jamedinova[SUP] 1 [/SUP], Ruslan Kurumbayev[SUP] 1 [/SUP], Maksim Pivin[SUP] 3 [/SUP]
Affiliations
- PMID: 39872756
- PMCID: PMC11769847
- DOI: 10.2147/OAEM.S470523
Background: One of the most serious complications of coronary artery stenting is restenosis and in-stent thrombosis; their prevalence can reach 20-25%. Stent thrombosis can be acute (up to 24 hours), subacute (24 hours to 30 days), late (30 days to 1 year), and very late (> 1 year after previous stenting). In the patients with COVID-19 in intensive care units, the proportion of those with elevated troponin levels reached 25%.
Objective: Evaluation of the association between COVID-19 and the development of in-stent thrombosis and restenosis of the coronary arteries based on the analysis of clinical cases and case series.
Materials and methods: We searched the PubMed and Scopus databases for relevant case reports and case series of stent restenosis and in-stent thrombosis associated with coronavirus infection (CVI) published between 2020 and the present. Thirty-eight full-text publications were screened and manually checked for analysis. We found 10 publications describing cases of thrombosis and restenosis of stents associated with coronavirus infection, of which only 2 were case series. In total, we analyzed 22 cases.
Results: In the structure of in-stent restenosis and thrombosis, 59.1% were very late, 9.1% were late; 18.2% were considered subacute events, and 13.6% were acute events. All cases were angiographically confirmed. The main location of restenosis or thrombosis was the left coronary artery (LAD) (51.1%), thrombosis of the right coronary artery (RCA) occurred in 27.3%, and location in circumflex artery was in 22.7%. All patients had COVID-19 confirmed by a PCR test or the presence of immunoglobulins G and M. In fourteen patients (54.5%), an X-ray examination showed the presence of bilateral polysegmental infiltration.
Conclusion: Analysis of publications demonstrates the association between restenosis and in-stent thrombosis in patients with coronary arteries disease (CAD) and coronavirus infection.
Keywords: COVID-19; case report; case series; coronary artery disease; in-stent thrombosis; restenosis; stenting.